Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
China
MedTech
Illumina sales flat in Q3 amid China headwinds
Illumina’s revenue was flat for the third quarter as the sequencing giant continues to deal with headwinds from a China sales ban.
Ben Adams
Oct 31, 2025 8:55am
Roche pens $1B deal for respiratory bispecific from China
Oct 30, 2025 5:04am
China pricing pressure weighs on Roche's diagnostics business
Oct 23, 2025 8:40am
Hansoh, Chugai ink separate and lucrative licensing agreements
Oct 17, 2025 11:04am
Kite puts $1.64B on the line for Pregene's in vivo CAR-Ts
Oct 16, 2025 4:56pm
'Let that one go': Nkarta CEO urges US gov to drop China regs
Oct 16, 2025 2:00pm
